These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 729611)
1. Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers. Aellig WH Eur J Clin Pharmacol; 1978 Nov; 14(3):167-9. PubMed ID: 729611 [TBL] [Abstract][Full Text] [Related]
2. Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers. Bennett PN; Bennett J; Bradbrook I; Francis J; John VA; Rogers H; Turner P; Warrington SJ Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):171S-175S. PubMed ID: 4005119 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation. Kerr MJ; Harron DW; Kinney C; Shanks RG Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463 [TBL] [Abstract][Full Text] [Related]
4. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers. Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120 [TBL] [Abstract][Full Text] [Related]
11. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise. Bobik A; Jennings GL; Korner PI; Ashley P; Jackman G Br J Clin Pharmacol; 1979 Jun; 7(6):545-9. PubMed ID: 465276 [TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol. Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747 [TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris. Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729 [TBL] [Abstract][Full Text] [Related]
14. Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practice. Forrest WA J Int Med Res; 1979; 7(4):318-23. PubMed ID: 488521 [No Abstract] [Full Text] [Related]
15. The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat. Abrahamsson T Br J Pharmacol; 1986 Apr; 87(4):657-64. PubMed ID: 2871880 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopharmacological studies with pindolol following intravenous and oral administration]. Aellig WH Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris. Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB Eur J Clin Pharmacol; 1987; 32(2):127-33. PubMed ID: 3556193 [TBL] [Abstract][Full Text] [Related]
18. Experiments with pindolol (Visken) in healthy volunteers. Aellig WH Med J Aust; 1977 Sep; 2(SP2):8-11. PubMed ID: 927284 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs. Kantelip JP; Duchene-Marullaz P; Delaigue-Fabry R; Eschalier A Br J Clin Pharmacol; 1982; 13(Suppl 2):159S-166S. PubMed ID: 6125165 [TBL] [Abstract][Full Text] [Related]
20. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers. Aellig WH Br J Clin Pharmacol; 1976 Apr; 3(2):251-7. PubMed ID: 973959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]